@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .

<https://lod.nal.usda.gov/naltv#marc001> rdfs:label "Field 001 in MARC Authority Format"@en .
nalt:148788_def
  a <https://lod.nal.usda.gov/naltv#Definition> ;
  rdf:value "A potent, long-acting synthetic somatostatin octapeptide analog that inhibits secretion of growth hormone and is used to treat hormone-secreting tumors; diabetes mellitus; hypotension, orthostatic; hyperinsulinism; hypergastrinemia; and small bowel fistula."@en, "Potente octapéptido análogo de la somatostatina, de acción sintética prolongada que inhibe la secreción de la hormona del crecimiento y se utiliza para tratar tumores secretores de hormonas; diabetes mellitus; hipotensión, ortostática; hiperinsulinismo; hipergastrinemia y fístula del intestino delgado."@es ;
  dc:source "Medical Subject Headings 2011" .

<https://lod.nal.usda.gov/nalt>
  a skos:ConceptScheme ;
  rdfs:label "NALT Full"@en .

<https://lod.nal.usda.gov/naltv#Chemical>
  a owl:Class ;
  rdfs:label "Chemical"@en .

nalt:148788
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  dc:created "2011-10-06"^^xsd:date ;
  dc:modified "2012-11-30"^^xsd:date ;
  skos:broader nalt:31026 ;
  skos:definition nalt:148788_def ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> ;
  skos:prefLabel "octreotide"@es, "octreotide"@en ;
  skos:related nalt:3816 ;
  ns0:marc001 "59952" .

nalt:31026
  a ns0:Chemical, skos:Concept ;
  skos:narrower nalt:148788 ;
  skos:prefLabel "cyclic peptides"@en, "péptidos cíclicos"@es .

nalt:3816
  a ns0:Chemical, skos:Concept ;
  skos:prefLabel "agentes antineoplásicos"@es, "antineoplastic agents"@en ;
  skos:related nalt:148788 .